Mucosa-interfacing electronics
- PMID: 36124042
- PMCID: PMC9472746
- DOI: 10.1038/s41578-022-00477-2
Mucosa-interfacing electronics
Abstract
The surface mucosa that lines many of our organs houses myriad biometric signals and, therefore, has great potential as a sensor-tissue interface for high-fidelity and long-term biosensing. However, progress is still nascent for mucosa-interfacing electronics owing to challenges with establishing robust sensor-tissue interfaces; device localization, retention and removal; and power and data transfer. This is in sharp contrast to the rapidly advancing field of skin-interfacing electronics, which are replacing traditional hospital visits with minimally invasive, real-time, continuous and untethered biosensing. This Review aims to bridge the gap between skin-interfacing electronics and mucosa-interfacing electronics systems through a comparison of the properties and functions of the skin and internal mucosal surfaces. The major physiological signals accessible through mucosa-lined organs are surveyed and design considerations for the next generation of mucosa-interfacing electronics are outlined based on state-of-the-art developments in bio-integrated electronics. With this Review, we aim to inspire hardware solutions that can serve as a foundation for developing personalized biosensing from the mucosa, a relatively uncharted field with great scientific and clinical potential.
Keywords: Biomedical engineering; Sensors and biosensors.
© Springer Nature Limited 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Competing interestsFinancial competing interests for G.T. that may be interpreted as related to the current manuscript include current and prior funding from Novo Nordisk, Hoffman La Roche, Oracle, Draper Laboratory, MIT Lincoln Laboratory, NIH (NIBIB and NCI), Bill and Melinda Gates Foundation, The Leona M. and Harry B. Helmsley Charitable Trust, Karl van Tassel (1925) Career Development Professor, MIT and the Defense Advanced Research Projects Agency, as well as employment by the Massachusetts Institute of Technology and Brigham and Women’s Hospital. Personal financial interests include equity/stock (Lyndra Therapeutics, Suono Bio, Vivtex, Celero Systems, Syntis Bio), board of directors member and/or consultant (Lyndra Therapeutics, Novo Nordisk, Suono Bio, Vivtex, Celero Systems, Syntis Bio) and royalties (past and potentially in the future) from licensed and/or optioned intellectual property (Lyndra Therapeutics, Novo Nordisk, Suono Bio, Vivtex, Celero Systems, Syntis Bio, Johns Hopkins, MIT, Mass General Brigham Innovation). Complete details of all relationships for profit and not-for-profit for G.T. can be found in the supplementary information. K.N. and G.T. report a patent application (U.S. Provisional Application no. 63/301,491) describing a flexible silicone liquid-metal-filled manometry system. G.T. reports the following patents and/or patent applications: U.S. patent no. 10,149,635 describing ingestible devices for physiological status monitoring, U.S. patent nos. 10,182,985, 10,413,507, 10,517,819, 10,517,820, 10,532,027, 10,596,110, 10,610,482, 10,716,751 and 10,716,752 describing gastric residence structures and materials supporting safe residence and GI transit, U.S. patent nos. 10,693,544 and 10,879,983 describing methods for charging of GI devices through RF transmission, U.S. patent no. 11,207,272 describing a device with gastric anchoring capabilities and the capacity for electrical stimulation and sensing, U.S. Provisional Application patent no. 16/152,785 describing a flexible piezoelectric device that can sense deformation in the GI tract, U.S. Provisional Application patent no. 16/207,647 a gastric resident electronic device, U.S. Provisional Application patent no. 17/470,942 describing a gastric resident system capable of sensing radiation and toxic agents and releasing therapeutics, U.S. Provisional Application patent no. 63/246,761 describing a nasogastric system for biochemical sensing and U.S. Provisional Application patent no. 63/294,902 describing a system for energy harvesting from the GI tract. All other authors declare no competing interests.
Figures
References
-
- Neuman MR, et al. Advances in medical devices and medical electronics. Proc. IEEE. 2012;100:1537–1550. doi: 10.1109/JPROC.2012.2190684. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous